Solid combination of budesonide and formoterol in the treatment of asthma bronchiale;Feste kombination von budesonid und formoterol zur therapie des asthma bronchiale

Pneumologie

Volumn 55, Issue 3, 2001, Pages 159-162

  Gillissen, A ^a   Buhl, R ^a   Magnussen, H ^a   Menz, G ^a   Rabe, K ^a   Vogelmeier, C ^a   Worth, H ^a  

^a Robert Koch Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FLUTICASONE; FORMOTEROL; GLUCOCORTICOID; SALMETEROL;

ASTHMA; DEVICE; DRUG EFFICACY; DRUG INDICATION; HUMAN; MONOTHERAPY; NOTE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; HUMANS;

EID: 0035103231     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12436     Document Type: Note

References (44)

1. Added salmeterol versus higher-dose corticosteroids in asthma patients with symptoms on existing inhaled corticosteroid
2. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
3. Effect of inhaled formoterol and budesonide on exacerbations of asthma
4. 2 agonist, inhaled corticosteroid and their combination in the treatment of asthma
5. Wirksamkeit und verträglichkeit einer kombination von fluticason und salmeterol bei patienten mit obstruktiver atemwegserkrankung
6. The complementary role of glucocorticosteroids and long-acting β-adrenergic agonists
7. Interactions between corticosteroids and beta agonists
8. 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
9. Adding formoterol to budesonide in moderate asthmatics is cost-effective - Results from the "FACET" study
10. 2-agonists in management of childhood asthma: A critical review of the literature
11. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma
12. Salmeterol and fluticasone propionated (50/250μg) administered via combination diskus inhaler: As effective as when given via separate diskus inhalers
13. Salmeterol/fluticasone combination inhaler. A new, effective and well tolerated treatment for asthma
14. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma
15. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial
16. Salmeterol/fluticasone propionate combination therapy 50/250μg twice daily is more effective than budesonide 800μg twice daily in treating moderate to severe asthma
17. 2-sympathomimetika zur langzeittherapie des asthma bronchiale
18. Budesonide and formoterol in a single inhaler, Symbicort®, improves asthma control in adults: A randomised controlled study
19. The new single inhaler product containing both budesonide/formoterol improves asthma control in adults
20. Efficacy and safety of a new single inhaler product, containing both budesonide and formoterol in adult asthma
21. Improved lung function and rapid control achieved with the new single inhaler product containing both budesonide and formoterol in asthmatic children aged 4-17 years
22. The benefit of the new single inhaler product containing both budesonide and formoterol in asthmatic children
23. Measuring compliance with inhaled medication in asthma
24. Asthma controller medications: What do patients want?
25. Die behandlung des asthma bronchiale nach einem bedarfsorientierten behandlungsplan
26. Compliance and outcomes in patients with asthma
27. How often is medication taken as prescribed?
28. Treatment with inhaled steroids in asthma and chronic bronchitis: Long term compliance and inhaler technique
29. 2-agonists
30. Does urinary salbutamol reflect compliance with the aerosol regimen in patients with asthma
31. Patient compliance with inhaled medication: Does combining beta-agonists with corticosteroids improve compliance?
32. Comparison of patients' compliance with prescribed oral and inhaled asthma medications
33. Difficult asthma
34. A high dose of budesonid/formoterol in a single inhaler was well tolerated by asthmatic patients
35. The british guidelines on asthma management. Asthma in adults and schoolchildren
36. Asthmatherapie bei kindern und erwachsenen. Empfehlungen der deutschen atemwegsliga in der deutschen gesellschaft für pneumologie
37. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma
38. On demand treatment: Comparison of formoterol and terbutaline in moderate asthma
39. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: Onset of action, duration of effect and potency
40. Comparative studies of inhaled salmeterol with other bronchodilators
41. Inhalierbare kortikosteroide in der langzeittherapie der COPD. Stellungnahme eines expertengremiums